Igor Vivanco
Impact in
- Cancer Research top 1%
- Cancer Genomics and Diagnostics
- Cancer, Hypoxia, and Metabolism
- Genetics top 0.5%
- Glioma Diagnosis and Treatment
Papers in
-
- Cancer Genomics and Diagnostics 4
-
- PI3K/AKT/mTOR signaling in cancer 10
- Protein Degradation and Inhibitors 3
- Co-authors
- Charles L. Sawyers (5 shared papers)Ingo K. Mellinghoff (11 shared papers)Chris Tran (2 shared papers)René Hubert (2 shared papers)James Chun-Yen Kuo (2 shared papers)Arthur B. Raitano (2 shared papers)Emily Chen (2 shared papers)Douglas C. Saffran (2 shared papers)
- Journals
- Proceedings of the National Academy of Sciences (4 papers)Cancer Cell (2 papers)Journal of Clinical Investigation (2 papers)British Journal of Cancer (2 papers)Cancer Research (2 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Igor Vivanco
35 papers receiving 10.6k citations
Igor Vivanco's Hit Papers
Peers
Comparison fields: 5 of 136
- Cancer Research 2.2k
- Genetics 1.6k
- Oncology 2.6k
- Molecular Biology 6.5k
- Pulmonary and Respiratory Medicine 1.9k
Countries citing papers authored by Igor Vivanco
This map shows the geographic impact of Igor Vivanco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Igor Vivanco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Igor Vivanco more than expected).
Fields of papers citing papers by Igor Vivanco
This network shows the impact of papers produced by Igor Vivanco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Igor Vivanco. The network helps show where Igor Vivanco may publish in the future.
Co-authors
The 25 scholars most cited alongside Igor Vivanco, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The phosphatidylinositol 3-Kinase–AKT pathway in human cancer Hit paper breakdown → | 2002 | 5153 |
| 2 | Molecular Determinants of the Response of Glioblastomas to EGFR Kinase Inhibitors Hit paper breakdown → | 2005 | 1193 |
| 3 | Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma Hit paper breakdown → | 2007 | 870 |
| 4 | 2009 | 346 | |
| 5 | 2009 | 318 | |
| 6 | 1999 | 305 | |
| 7 | 2006 | 302 | |
| 8 | 2012 | 288 | |
| 9 | 2004 | 284 | |
| 10 | 2009 | 232 | |
| 11 | Catalytic cleavage of the androgen-regulated TMPRSS2 protease results in its secretion by prostate and prostate cancer epithelia. | 2001 | 219 |
| 12 | 2007 | 204 | |
| 13 | 2006 | 202 | |
| 14 | 2012 | 181 | |
| 15 | 2007 | 141 | |
| 16 | 2010 | 94 | |
| 17 | 2014 | 76 | |
| 18 | 2020 | 60 | |
| 19 | 2002 | 49 | |
| 20 | 2021 | 48 |
About Igor Vivanco
Igor Vivanco is a scholar working on Cancer Research, Molecular Biology, Oncology, Pulmonary and Respiratory Medicine and Cell Biology, having authored 35 papers that have together received 10.9k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (10 papers), Lung Cancer Treatments and Mutations (5 papers), Cancer Genomics and Diagnostics (4 papers), Prostate Cancer Treatment and Research (4 papers), Estrogen and related hormone effects (3 papers), Protein Degradation and Inhibitors (3 papers), Cancer Mechanisms and Therapy (3 papers) and Glioma Diagnosis and Treatment (2 papers). The work is most often cited by research in Cancer Research (2.2k citations), Genetics (1.6k citations), Oncology (2.6k citations), Molecular Biology (6.5k citations) and Pulmonary and Respiratory Medicine (1.9k citations). Igor Vivanco has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Charles L. Sawyers, Ingo K. Mellinghoff, Chris Tran, René Hubert, James Chun-Yen Kuo, Arthur B. Raitano, Emily Chen, Douglas C. Saffran, Aya Jakobovits and Daniel Afar. Their work appears in journals such as Proceedings of the National Academy of Sciences, Cancer Cell, Journal of Clinical Investigation, British Journal of Cancer and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.